Frank R. Cruz firm notifies Replimune investors of securities fraud class action

By Atlas Watchline Staff · Legal · August 11, 2026

The Law Offices of Frank R. Cruz says Replimune Group investors who lost money may seek to participate in a securities fraud class action tied to allegations about the company’s disclosures.

The Law Offices of Frank R. Cruz says Replimune Group investors who lost money may seek to participate in a securities fraud class action tied to allegations about the company’s disclosures.

In a press release dated Aug. 11, 2026, the firm said investors in Replimune Group Inc. may contact it about a securities fraud class action involving the company’s stock. The notice said the case concerns alleged misstatements and omissions between Oct. 20, 2025 and Apr. 10, 2026.

The firm said the complaint seeks to represent investors who suffered losses in the company’s shares, which trade under the ticker REPL.

According to the press release, the complaint alleges defendants made materially false or misleading statements and failed to disclose adverse facts. The release says those alleged omissions included study design concerns previously communicated by the U.S. Food and Drug Administration that were not addressed in connection with the BLA, or biologics license application.

The release also says the company submitted data from an early unplanned analysis of RP1-104 covering 40 patients, which it described as 10% of the planned enrollment of 400 patients. It further alleges that RPL-001-16 and RP1-104 had deficiencies likely to lead the FDA to reject the BLA.

The firm said the lead plaintiff deadline is Oct. 5, 2026. It also said an investor does not need to take action to remain an absent class member. The press release said it may be considered attorney advertising in some jurisdictions.

The announcement did not include a response from Replimune. The press release provided contact information for the law firm and said investors could seek more information through the firm.

What happens next is tied to the court process and the lead plaintiff deadline named in the notice. The release does not say when a hearing or other court event may occur.

Sources

• PR Newswire press release: Replimune Group, Inc. shareholders who lost money have opportunity to lead securities fraud lawsuit

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

This is the AMP version of the article. Read the full article on Atlas Watchline.